View More View Less
  • 1 Faculty of Science, Department of Biology, Çankiri Karatekin University, Çankiri, Turkey
  • | 2 Faculty of Medicine, Department of Medical Microbiology, Manisa Celal Bayar University, Manisa, Turkey
  • | 3 Faculty of Agriculture, Department of Agricultural Biotechnology, Ondokuz Mayis University, Samsun, Turkey
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Immunogenic potency of the recombinant Erp, HspR, LppX, MmaA4, and OmpA proteins from Mycobacterium tuberculosis (MTB), formulated with Montanide ISA 720 VG adjuvant, was evaluated in BALB/c mice for the first time in this study. The five vaccine formulations, adjuvant, and BCG vaccine were subcutaneously injected into mice, and the sera were collected at days 0, 15, 30, 41, and 66. The humoral and cellular immune responses against vaccine formulations were determined by measuring serum IgG and serum interferon-gamma (IFN-γ) and interleukin-12 (IL-12) levels, respectively. All formulations significantly increased IgG levels post-vaccination. The highest increase in IFN-γ level was provided by MmaA4 formulation. The Erp, HspR, and LppX formulations were as effective as BCG in enhancement of IFN-γ level. The most efficient vaccine boosting the IL-12 level was HspR formulation, especially at day 66. Erp formulation also increased the IL-12 level more than BCG at days 15 and 30. The IL-12 level boosted by MmaA4 formulation was found to be similar to that by BCG. OmpA formulation was inefficient in enhancement of cellular immune responses. This study showed that MmaA4, HspR, and Erp proteins from MTB are successful in eliciting both humoral and cellular immune responses in mice.

Supplementary Materials

    • Supplementary Material
  • 1.

    Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., 3rd, Tekaia, F., Badcock, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R., Devlin, K., Feltwell, T., Gentles, S., Hamlin, N., Holroyd, S., Hornsby, T., Jagels, K., Krogh, A., McLean, J., Moule, S., Murphy, L., Oliver, K., Osborne, J., Quail, M. A., Rajandream, M. A., Rogers, J., Rutter, S., Seeger, K., Skelton, J., Squares, R., Squares, S., Sulston, J. E., Taylor, K., Whitehead, S., Barrell, B. G.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537544 (1998).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    World Health Organization [WHO]: Global Tuberculosis Report 2017. Accessed on September 18, 2018, from http://www.who.int/entity/tb/publications/global_report/MainText_13Nov2017.pdf?ua=1

    • Search Google Scholar
    • Export Citation
  • 3.

    Agger, E. M., Andersen, P.: Tuberculosis subunit vaccine development: On the role of interferon-γ. Vaccine 19, 22982302 (2001).

  • 4.

    Pathan, A. A., Sander, C. R., Fletcher, H. A., Poulton, I., Alder, N. C., Beveridge, N. E., Whelan, K. T., Hill, A. V., McShane, H.: Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: Different boosting intervals and implications for efficacy trials. PLoS One 2, e1052 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Horwitz, M. A., Harth, G.: A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71, 1672 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., Cole, S. T.: Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9, 533539 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Zhao, S., Zhao, Y., Mao, F., Zhang, C., Bai, B., Zhang, H., Shi, C., Xu, Z.: Protective and therapeutic efficacy of Mycobacterium smegmatis expressing HBHA-hIL12 fusion protein against Mycobacterium tuberculosis in mice. PLoS One 7, e31908 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Sibley, L., Reljic, R., Radford, D. S., Huang, J. M., Hong, H. A., Cranenburgh, R. M., Cutting, S. M.: Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model. FEMS Microbiol Lett 358, 170179 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Liu, W., Li, J., Niu, H., Lin, X., Li, R., Wang, Y., Xin, Q., Yu, H., Wu, Y., Zhu, B., Tan, J.: Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice. Int Immunopharmacol 53, 8389 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Smith, I.: Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16, 463 (2003).

  • 11.

    Sulzenbacher, G., Canaan, S., Bordat, Y., Neyrolles, O., Stadthagen, G., Roig-Zamboni, V., Rauzier, J., Maurin, D., Laval, F., Daffé, M., Cambillau, C., Gicquel, B., Bourne, Y., Jackson, M.: LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J 25, 14361444 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Junqueira-Kipnis, A. P., Marques Neto, L. M., Kipnis, A.: Role of fused Mycobacterium tuberculosis immunogens and adjuvants in modern tuberculosis vaccines. Front Immunol 5, 188 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Kang, H., Yuan, Q., Ma, H., Hu, Z. D., Han, D. P., Wu, K., Lowrie, D. B., Fan, X. Y.: Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic IL-2-producing CD4 T cell frequency post-vaccination. Immunology 143, 661669 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Osorio, Y., Cohen, J., Ghiasi, H.: Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest Ophthalmol Vis Sci 45, 506514 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Okay, S., Özcengiz, E., Gürsel, I., Özcengiz, G.: Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A:3 in mice. Res Vet Sci 93, 12611265 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Laemmli, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685 (1970).

  • 17.

    Bradford, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248254 (1976).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Scalzo, A. A., Elliott, S. L., Cox, J., Gardner, J., Moss, D. J., Suhrbier, A.: Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J Virol 69, 13061309 (1995).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Mutiso, J. M., Macharia, J. C., Taracha, E., Gicheru, M. M.: Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops). J Biomed Res 26, 816 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Towbin, H., Staehelin, T., Gordon, J.: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A 76, 43504354 (1979).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Dai, G., Rady, H. F., Huang, W., Shellito, J. E., Mason, C., Ramsay, A. J.: Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Vaccine 34, 62676275 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Liang, Y., Zhang, X., Bai, X., Xiao, L., Wang, X., Zhang, J., Yang, Y., Song, J., Wang, L., Wu, X.: Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice. BMC Immunol 18, 11 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Delogu, G., Brennan, M. J.: Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun 69, 56065611 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Yoshida, S., Tanaka, T., Kita, Y., Kuwayama, S., Kanamaru, N., Muraki, Y., Hashimoto, S., Inoue, Y., Sakatani, M., Kobayashi, E., Kaneda, Y., Okada, M.: DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. Vaccine 24, 11911204 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Liang, Y., Wu, X., Zhang, J., Xiao, L., Yang, Y., Bai, X., Yu, Q., Li, Z., Bi, L., Li, N., Wu, X.: Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 66, 419426 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Zhang, M., Dong, C., Xiong, S.: Vesicular stomatitis virus-vectored multi-antigen tuberculosis vaccine limits bacterial proliferation in mice following a single intranasal dose. Front Cell Infect Microbiol 7, 34 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Nyendak, M., Swarbrick, G. M., Duncan, A., Cansler, M., Huff, E. W., Hokey, D., Evans, T., Barker, L., Blatner, G., Sadoff, J., Douoguih, M., Pau, M. G., Lewinsohn, D. A., Lewinsohn, D. M.: Adenovirally-induced polyfunctional T cells do not necessarily recognize the infected target: Lessons from a phase I trial of the AERAS-402 vaccine. Sci Rep 6, 36355 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Li, W., Deng, G., Li, M., Zeng, J., Zhao, L., Liu, X., Wang, Y.: A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice. Mol Immunol 62, 8695 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Kwon, K. W., Kim, W. S., Kim, H., Han, S. J., Hahn, M. Y., Lee, J. S., Nam, K. T., Cho, S. N., Shin, S. J.: Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hypervirulent Mycobacterium tuberculosis strain K. Sci Rep 7, 44151 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Larrouy-Maumus, G., Layre, E., Clark, S., Prandi, J., Rayner, E., Lepore, M., de Libero, G., Williams, A., Puzo, G., Gilleron, M.: Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine 35, 13951402 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Xue, Y., Bai, Y., Gao, X., Jiang, H., Wang, L., Gao, H., Xu, Z.: Expression, purification and characterization of Mycobacterium tuberculosis RpfE protein. J Biomed Res 26, 1723 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Kocíncová, D., Sondén, B., de Mendonça-Lima, L., Gicquel, B., Reyrat, J. M.: The Erp protein is anchored at the surface by a carboxy-terminal hydrophobic domain and is important for cell-wall structure in Mycobacterium smegmatis. FEMS Microbiol Lett 231, 191196 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Berthet, F. X., Lagranderie, M., Gounon, P., Laurent-Winter, C., Ensergueix, D., Chavarot, P., Thouron, F., Maranghi, E., Pelicic, V., Portnoï, D., Marchal, G., Gicquel, B.: Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282, 759762 (1998).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    de Mendonça-Lima, L., Bordat, Y., Pivert, E., Recchi, C., Neyrolles, O., Maitournam, A., Gicquel, B., Reyrat, J. M.: The allele encoding the mycobacterial Erp protein affects lung disease in mice. Cell Microbiol 5, 6573 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35.

    Martinez, V., Carcelain, G., Badell, E., Jouan, M., Mauger, I., Sellier, P., Truffot, C., Bricaire, F., Arend, S. M., Ottenhoff, T., Autran, B., Gicquel, B.: T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals. BMC Infect Dis 7, 83 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Yang, Y., Auguin, D., Delbecq, S., Dumas, E., Molle, G., Molle, V., Roumestand, C., Saint, N.: Structure of the Mycobacterium tuberculosis OmpATb protein: A model of an oligomeric channel in the mycobacterial cell wall. Proteins 79, 645661 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Dao, D. N., Sweeney, K., Hsu, T., Gurcha, S. S., Nascimento, I. P., Roshevsky, D., Besra, G. S., Chan, J., Porcelli, S. A., Jacobs, W. R.: Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4, e1000081 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Derrick, S. C., Dao, D., Yang, A., Kolibab, K., Jacobs, W. R., Morris, S. L.: Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis. PLoS One 7, e32959 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Bell, C., Smith, G. T., Sweredoski, M. J., Hess, S.: Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: A comprehensive resource for tuberculosis research. J Proteome Res 11, 119130 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Stewart, G. R., Snewin, V. A., Walzl, G., Hussell, T., Tormay, P., O’Gaora, P., Goyal, M., Betts, J., Brown, I. N., Young, D. B.: Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 7, 732737 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Lefèvre, P., Denis, O., De Wit, L., Tanghe, A., Vandenbussche, P., Content, J., Huygen, K.: Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis. Infect Immun 68, 10401047 (2000).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42.

    Prados-Rosales, R., Carreño, L., Cheng, T., Blanc, C., Weinrick, B., Malek, A., Lowary, T. L., Baena, A., Joe, M., Bai, Y., Kalscheuer, R., Batista-Gonzalez, A., Saavedra, N. A., Sampedro, L., Tomás, J., Anguita, J., Hung, S. C., Tripathi, A., Xu, J., Glatman-Freedman, A., Jacobs, W. R., Jr., Chan, J., Porcelli, S. A., Achkar, J. M., Casadevall, A.: Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog 13, e1006250 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 5 0 0
Jun 2021 7 0 0
Jul 2021 14 0 0
Aug 2021 12 2 2
Sep 2021 18 0 0
Oct 2021 10 0 0
Nov 2021 0 0 0